After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Most recently, Yahoo Finance reported about the stock as it publicized that Beam Therapeutics to Participate in Upcoming March 2024 Investor Conferences.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Beam Therapeutics Inc is $3.12B. A total of 1.06 million shares were traded on the day, compared to an average of 1.46M shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, BEAM has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 29,549 shares. Over the last 12 months, there were 12 BUYs and 17 SELLs from insiders. Insiders purchased 339,931 shares during that period but sold 228,463.
In the most recent transaction, FMR LLC sold 900,000 shares of BEAM for 30.55 per share on Feb 14. After the transaction, the See Remark 1 now owns 1,235,511 company shares. In a previous transaction on Feb 13, FMR LLC sold 1,565 shares at 30.76 per share. BEAM shares that See Remark 1 owns now total 2,771,913.
Among the insiders who sold shares, Evans John M. disposed of 60,000 shares on Jan 31 at a per-share price of $25.33. This resulted in the CEO holding 1,058,262 shares of BEAM after the transaction. In another insider transaction, Bellon Christine sold 1,907 shares at $26.42 per share on Jan 03. Company shares held by the Chief Legal Officer now total 80,495.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, BEAM has a high of $49.50 and a low of $16.95.
As of this writing, BEAM has an earnings estimate of -$1.39 per share for the current quarter. EPS was calculated based on a consensus of 12 estimates, with a high estimate of -$1 per share and a lower estimate of -$2.16. The company reported an EPS of -$1.22 in the last quarter, which was 10.30% higher than expectations of -$1.36.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BEAM’s latest balance sheet shows that the firm has $965.65M in Cash & Short Term Investments as of fiscal 2021. There were $142.35M in debt and $213.44M in liabilities at the time. Its Book Value Per Share was $12.02, while its Total Shareholder’s Equity was $826.74M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BEAM is Buy with a score of 4.07.
